康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300869 康泰医学

已收盘 12-19 15:00:00

{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":15.59,"timestamp":1766127828000,"preClose":15.51,"halted":0,"volume":2881790,"delay":0,"changeRate":0.0052,"floatShares":252999999,"shares":401999999,"eps":-0.1952,"marketStatus":"已收盘","change":0.08,"latestTime":"12-19 15:00:00","open":15.48,"high":15.63,"low":15.48,"amount":44862000,"amplitude":0.0097,"askPrice":15.59,"askSize":74,"bidPrice":15.58,"bidSize":213,"shortable":0,"etf":0,"ttmEps":-0.1952,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"adjPreClose":15.51,"symbolType":"stock","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":17.06,"lowLimit":13.96,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401803197,"isCdr":false,"pbRate":3.59,"roa":"--","roe":"0.52%","epsLYR":-0.19,"committee":-0.367284,"marketValue":6264000000,"turnoverRate":0.0114,"status":0,"floatMarketCap":3950000000},"requestUrl":"/m/hq/s/300869","defaultTab":"news","newsList":[{"id":"2588741006","title":"科力装备：为康泰医学开发额温枪部件","url":"https://stock-news.laohu8.com/highlight/detail?id=2588741006","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588741006?lang=zh_cn&edition=full","pubTime":"2025-12-01 15:04","pubTimestamp":1764572659,"startTime":"0","endTime":"0","summary":"证券之星消息，科力装备12月01日在投资者关系平台上答复投资者关心的问题。财报显示贵司积极拓展医疗器械（额温枪）等非汽车零部件领域。2020 年初，外部不利因素的出现，医疗器械企业康泰医学的额温枪产品供不应求，其原有额温枪结构件供应商产能难以支撑爆发式增长的订单。公司应康泰医学的紧急求助，为其开发模具和生产额温枪整体结构部件和脉搏血氧仪壳体部件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100012186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0264","301552","300869"],"gpt_icon":0},{"id":"2586258897","title":"康泰医学（300869）披露迪拜子公司成立进展，11月26日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258897?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:48","pubTimestamp":1764150515,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，康泰医学报收于16.68元，较前一交易日上涨0.06%，最新总市值为67.02亿元。该股当日开盘16.65元，最高17.27元，最低16.61元，成交额达9238.99万元，换手率为2.15%。公司近日发布公告称，其在迪拜设立子公司的事项已取得新进展。根据公告，康泰医学系统（秦皇岛）股份有限公司已于近期完成子公司CONTEC GLOBAL INVESTMENT FZCO的注册并取得贸易许可证。此次对外投资事项已于2025年7月14日经公司第四届董事会第二十次会议审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2585619054","title":"11月24日康泰医学发布公告，股东减持81.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585619054","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585619054?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:01","pubTimestamp":1763985671,"startTime":"0","endTime":"0","summary":"证券之星消息，11月24日康泰医学发布公告《康泰医学:关于持股5%以上股东、部分董事及高级管理人员减持计划实施完毕的公告》，其股东王桂丽于2025年10月16日至2025年11月24日间合计减持81.66万股，占公司目前总股本的0.2032%，变动期间该股股价上涨1.47%，截止11月24日收盘报16.56元。股东增减持详情见下表：根据康泰医学2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400030272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2585439241","title":"康泰医学：11月20日高管杨志山、郑敏、寇国治、许云龙减持股份合计4000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585439241","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585439241?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:03","pubTimestamp":1763730184,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月21日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月20日公司董事,高管杨志山、董秘,高管郑敏、高管寇国治、高管许云龙共减持公司股份4000.0股，占公司总股本为0.0008%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100037414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2584131062","title":"康泰医学：11月19日高管寇国治减持股份合计5.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584131062","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584131062?lang=zh_cn&edition=full","pubTime":"2025-11-20 21:03","pubTimestamp":1763643781,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月20日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月19日公司高管寇国治共减持公司股份5.9万股，占公司总股本为0.0147%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入619.14万，融资余额增加；融券净流入0.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000036031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2584949077","title":"康泰医学：11月18日高管寇国治、付春元减持股份合计42万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584949077","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584949077?lang=zh_cn&edition=full","pubTime":"2025-11-19 21:03","pubTimestamp":1763557380,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月19日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月18日公司高管寇国治、高管付春元共减持公司股份42.0万股，占公司总股本为0.1046%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入413.45万，融资余额增加；融券净流入0.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900037701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2584162564","title":"康泰医学：11月14日高管付春元减持股份合计2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584162564","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584162564?lang=zh_cn&edition=full","pubTime":"2025-11-17 21:03","pubTimestamp":1763384636,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月17日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月14日公司高管付春元共减持公司股份2.0万股，占公司总股本为0.005%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入825.03万，融资余额增加；融券净流入0.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700034085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2583159837","title":"康泰医学：11月12日高管付春元减持股份合计4.48万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583159837","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583159837?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:03","pubTimestamp":1763039012,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月13日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月12日公司高管付春元共减持公司股份4.48万股，占公司总股本为0.0111%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入610.66万，融资余额增加；融券净流入0.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300040378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2582614783","title":"康泰医学：11月10日高管付春元减持股份合计5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582614783","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582614783?lang=zh_cn&edition=full","pubTime":"2025-11-11 21:03","pubTimestamp":1762866201,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月11日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月10日公司高管付春元共减持公司股份5.0万股，占公司总股本为0.0124%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入253.91万，融资余额增加；融券净流入0.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100038481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2582879208","title":"康泰医学：11月7日高管付春元减持股份合计4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879208","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582879208?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:03","pubTimestamp":1762779793,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月10日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月7日公司高管付春元共减持公司股份4.0万股，占公司总股本为0.01%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出160.3万，融资余额减少；融券净流入0.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000032390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2579724899","title":"图解康泰医学三季报：第三季度单季净利润同比下降534.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579724899","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579724899?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:10","pubTimestamp":1761736222,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学2025年三季报显示，前三季度公司主营收入3.44亿元，同比上升3.03%；归母净利润939.98万元，同比下降5.08%；扣非净利润-339.72万元，同比上升47.39%；其中2025年第三季度，公司单季度主营收入1.26亿元，同比上升3.56%；单季度归母净利润-753.77万元，同比下降534.25%；单季度扣非净利润-1585.07万元，同比下降508.87%；负债率36.72%，投资收益663.32万元，财务费用-224.59万元，毛利率54.73%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"gpt_icon":0},{"id":"2579978796","title":"康泰医学(300869)9月30日股东户数3.47万户，较上期增加11.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579978796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579978796?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:37","pubTimestamp":1761730658,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学披露，截至2025年9月30日公司股东户数为3.47万户，较6月30日增加3587.0户，增幅为11.54%。在医疗器械行业个股中，康泰医学股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年6月30日至2025年9月30日，康泰医学区间涨幅为14.16%，在此期间股东户数增加3587.0户，增幅为11.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900036674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2578641667","title":"康泰医学：10月24日高管付春元减持股份合计20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2578641667","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578641667?lang=zh_cn&edition=full","pubTime":"2025-10-27 21:02","pubTimestamp":1761570150,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月27日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年10月24日公司高管付春元共减持公司股份20.0万股，占公司总股本为0.0498%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出266.47万，融资余额减少；融券净流出100.0，融券余额减少。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700034030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2577680228","title":"股市必读：10月21日康泰医学现4笔折价19.3%的大宗交易 合计成交837.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577680228","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577680228?lang=zh_cn&edition=full","pubTime":"2025-10-22 04:32","pubTimestamp":1761078730,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，康泰医学报收于16.32元，上涨1.62%，换手率1.48%，成交量3.75万手，成交额6075.46万元。交易信息汇总资金流向10月21日主力资金净流入58.73万元；游资资金净流出225.01万元；散户资金净流入166.28万元。大宗交易10月21日康泰医学发生4笔大宗交易，合计成交837.61万元，折价19.3%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200004107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2576834310","title":"10月20日康泰医学现1笔折价18.99%的大宗交易 合计成交234.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576834310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576834310?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:57","pubTimestamp":1760950638,"startTime":"0","endTime":"0","summary":"证券之星消息，10月20日康泰医学发生大宗交易，交易数据如下：大宗交易成交价格13.01元，相对当日收盘价折价18.99%，成交18万股，成交金额234.18万元，买方营业部为长江证券股份有限公司杭州秋涛北路证券营业部，卖方营业部为中信证券股份有限公司唐山大里北路证券营业部。近三个月该股共发生31笔大宗交易，合计成交7.36万手，折价成交31笔。截至2025年10月20日收盘，康泰医学报收于16.06元，上涨1.26%，换手率1.28%，成交量3.24万手，成交额5181.32万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000020690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"gpt_icon":0},{"id":"2576908592","title":"FDA一纸警告信，揭开了康泰医学的合规危机与出海困局","url":"https://stock-news.laohu8.com/highlight/detail?id=2576908592","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576908592?lang=zh_cn&edition=full","pubTime":"2025-10-17 14:36","pubTimestamp":1760682960,"startTime":"0","endTime":"0","summary":"近日，一封来自美国食品药品监督管理局的警告信，将康泰医学推至舆论风口。10月10日，公司公告披露，其位于河北秦皇岛的生产基地在FDA于6月进行的现场检查中，被认定不符合美国医疗器械质量体系规范，导致其产品被暂停进入美国市场。　　这不仅是康泰医学的一次合规失误，更是中国医疗器械企业“出海易、守海难”现实困境的缩影。行业经验表明，FDA警告信的整改周期通常在3至12个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-10-17/doc-infuetkm1563531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2575714130","title":"10月16日康泰医学发布公告，股东减持423.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575714130","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575714130?lang=zh_cn&edition=full","pubTime":"2025-10-16 18:01","pubTimestamp":1760608882,"startTime":"0","endTime":"0","summary":"证券之星消息，10月16日康泰医学发布公告《康泰医学:关于持股5%以上股东股份变动比例触及1%整数倍的公告》，其股东王桂丽于2025年9月23日至2025年10月15日间合计减持423.67万股，占公司目前总股本的1.0544%，变动期间该股股价下跌2.04%，截止10月15日收盘报16.32元。股东增减持详情见下表：根据康泰医学2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101600030037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2575204025","title":"10月15日康泰医学现4笔折价18.5%的大宗交易 合计成交872.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575204025","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575204025?lang=zh_cn&edition=full","pubTime":"2025-10-15 17:02","pubTimestamp":1760518965,"startTime":"0","endTime":"0","summary":"证券之星消息，10月15日康泰医学发生大宗交易，交易数据如下：近三个月该股共发生30笔大宗交易，合计成交7.18万手，折价成交30笔。该股近期无解禁股上市。截至2025年10月15日收盘，康泰医学(300869)报收于16.32元，上涨1.81%，换手率2.69%，成交量6.81万手，成交额1.11亿元。该股近半年内有股东持股变动，合计净减持694.59万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500026444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2575475629","title":"10月13日康泰医学现1笔折价17.03%的大宗交易 合计成交308.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575475629","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575475629?lang=zh_cn&edition=full","pubTime":"2025-10-13 16:31","pubTimestamp":1760344284,"startTime":"0","endTime":"0","summary":"证券之星消息，10月13日康泰医学发生大宗交易，交易数据如下：大宗交易成交价格13.4元，相对当日收盘价折价17.03%，成交23万股，成交金额308.2万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司唐山大里北路证券营业部。近三个月该股共发生26笔大宗交易，合计成交6.53万手，折价成交26笔。该股近期无解禁股上市。该股近半年内有股东持股变动，合计净减持694.59万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300015994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"gpt_icon":0},{"id":"2574129513","title":"康泰医学(300869.SZ)：FDA向公司出具警告信","url":"https://stock-news.laohu8.com/highlight/detail?id=2574129513","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574129513?lang=zh_cn&edition=full","pubTime":"2025-10-10 17:12","pubTimestamp":1760087524,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康泰医学 发布公告，公司于2025年10月2日收到美国食品药品监督管理局出具的警告信，该警告信基于FDA在2025年6月9日至2025年6月12日期间对位于河北省秦皇岛市的公司进行现场检查的结果。在该警告信关闭前，FDA正在采取措施拒绝公司产品进入美国，直至这些违规行为得到解决。因此，该事项未来可能会对公司在美国市场的正常经营活动产生一定影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康泰医学(300869.SZ)：FDA向公司出具警告信","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300869"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766352916792,"stockEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0999},{"period":"3month","weight":-0.0614},{"period":"6month","weight":0.1643},{"period":"1year","weight":0.032},{"period":"ytd","weight":0.1378}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.0143},{"period":"3month","weight":0.0184},{"period":"6month","weight":0.1579},{"period":"1year","weight":0.1544},{"period":"ytd","weight":0.1607}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"34665人(较上一季度增加11.54%)","perCapita":"7308股","listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","registeredCapital":"40180万元","survey":"　　康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是院线类产品、家用类产品、其他类产品。截至报告期末，公司及子公司共获得国内外有效专利484项，计算机软件著作权369项以及大量的技术储备。研发创新能力已经成为公司的核心竞争力之一。2025年4月，由河北工业大学牵头，复旦大学、燕山大学、康泰医学联合完成的“具身运动康复智能装备关键技术与应用”项目成果获得2024年度河北省科技进步奖一等奖。","listedPrice":10.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}